| WAB |
Report |
Adjusted EPS (2026Q2) |
BEAT |
pred ~$2.67 vs. cons $2.63 |
MEDIUM |
| WAB |
Report |
Revenue (2026Q2) |
BEAT |
pred ~$3.12B vs. cons $3.08B |
MEDIUM |
| WAB |
Report |
Adjusted operating margin (2026Q2) |
IN-LINE |
pred ~21.4% vs. cons 21.3% |
MEDIUM |
| WAB |
Guide |
Adjusted EPS guidance |
LOWER |
guide ~$10.55 midpoint vs. cons $10.60 (FY2026) |
MEDIUM |
| WAB |
Guide |
Revenue guidance |
LOWER |
guide ~$12.34B midpoint vs. cons $12.40B (FY2026) |
MEDIUM |
| WAB |
Return |
Day-1 residual (stock − beta × S&P 500) |
-0.8% |
— |
MEDIUM |
| WAB |
Return |
5-day cumulative residual |
-1.6% (FOLLOW-THROUGH) |
A modest 2026Q2 EPS beat of ~$2.67 vs. $2.63 is outweighed by FY2026 EPS guidance of ~$10.55 vs. $10.60 and revenue guidance of ~$12.34B vs. $12.40B, implying lower second-half estimates and continued post-report estimate revisions. |
MEDIUM |